Vimarsana
Biggest News Aggregation in the World

Page 10 - Evercore Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evercore Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evercore Group Today - Breaking & Trending Today

Interest jumps in US auction of shares in parent of Venezuela-owned Citgo - Vimarsana News

Interest jumps in US auction of shares in parent of Venezuela-owned Citgo

The latest oil and gas news, dedicated to all things oil and gas: people, technologies, transactions, trends, and macro-economic analysis that impact commodity prices.

Pension giant OMERS puts LifeLabs, Canada's biggest medical testing company, up for sale - Vimarsana News

Pension giant OMERS puts LifeLabs, Canada's biggest medical testing company, up for sale

LifeLabs has drawn multiple bidders and two health care companies have emerged as the leading contenders, sources say

Merck, Harpoon Therapeutics Agree to $680M Merger Deal - Vimarsana News

Merck, Harpoon Therapeutics Agree to $680M Merger Deal

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

Radio Giant Audacy Files for Bankruptcy, Enters RSA to Reduce Debt to $350MM from $1.9B - News - Vimarsana News

Radio Giant Audacy Files for Bankruptcy, Enters RSA to Reduce Debt to $350MM from $1.9B - News

Audacy entered into a restructuring support agreement with a supermajority of its debtholders on the terms of a comprehensive restructuring that will significantly deleverage its balance sheet and further position Audacy for long-term growth. Through the restructuring, Audacy and its debtholders will undertake a deleveraging transaction to equitize...

Drugmakers kick off industry conference with two cancer deals - Vimarsana News

Drugmakers kick off industry conference with two cancer deals

Johnson & Johnson and Merck on Monday announced plans to buy cancer therapy developers on the first day of a major U.S. healthcare conference, igniting what industry participants hope will be a strong...